NEW DELHI, Iune 22 (Xinhua) - Ua hōʻike ka mea hana lāʻau lapaʻau ʻo Bharat Biotech's Covaxin i ka 77.8 pakeneka o ka pono i nā hoʻokolohua pae III, ua hōʻike ʻia e nā pāpāho kūloko he nui i ka Pōʻalua.
"He 77.8 pakeneka ka pono o ka Covaxin a Bharat Biotech i ka pale ʻana i ka COVID-19, e like me ka ʻikepili mai nā hoʻokolohua pae III i mālama ʻia ma luna o 25,800 mau mea komo ma India," wahi a kahi hōʻike.
Ua puka mai ka helu pono i ka Pōʻalua ma hope o ka hālāwai ʻana o ke kōmike loea kumuhana (SEC) o ka Drugs Controller General of India (DCGI) a kūkākūkā i nā hopena.
Ua waiho ka ʻoihana lāʻau lapaʻau i ka ʻikepili hoʻāʻo pae III no ka lāʻau pale i ka DCGI i ka hopena pule.
Ua ʻōlelo ʻia nā hōʻike e manaʻo ʻia ka hui e mālama i kahi hālāwai "hoʻouna mua" me nā luna o ka World Health Organization i ka Pōʻakolu, e kūkākūkā i nā alakaʻi no ka waiho hope ʻana o ka ʻikepili a me nā palapala e pono ai.
Ua hoʻomaka ʻo India i ka hana pale nui ʻana no COVID-19 ma Ianuali 16 ma o ka hāʻawi ʻana i ʻelua mau lāʻau pale i hana ʻia ma India, ʻo ia hoʻi ʻo Covishield lāua ʻo Covaxin.
Ke hana nei ka Serum Institute of India (SII) i ka Covishield o ke Kulanui ʻo AstraZeneca-Oxford, ʻoiai ua hui pū ʻo Bharat Biotech me ka Indian Council of Medical Research (ICMR) i ka hana ʻana iā Covaxin.
Ua hoʻolaha ʻia hoʻi ka lāʻau pale Sputnik V i hana ʻia e Lūkini ma ka ʻāina.
Ka manawa hoʻouna: Iune-25-2021